Jan 23, 2019
Neovasc announces peer reviewed publication in JACC demonstrating objective evidence of improvement in perfusion after Reducer implantation
Dec 11, 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
Nov 20, 2018
JACC: Cardiovascular Interventions Publishes Peer Reviewed Article on Neovasc Reducer(TM) Patient Case
Oct 10, 2018
Neovasc Reducer(TM) Granted Breakthrough Device Designation from FDA
Oct 03, 2018
Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer(TM)
Sep 19, 2018
Neovasc Announces 100th Patient to Receive Reducer Therapy in Germany
Aug 09, 2018
BioCardia, Inc. Reports Second Quarter 2018 Financial Results and Business Highlights
Aug 08, 2018
Angina Pectoris Prevalence Forecast In 20 Major Markets 2018-2028: Analysis by Gender & 5 Year Age Cohort
Aug 06, 2018
Neovasc Announces Publication of Safety and Efficacy Results from REDUCE Study in International Journal of Cardiology
Jul 19, 2018
United States Coronary Chronic Total Occlusion System Market 2018-2024: Units Sold, Average Selling Prices, Product Pipeline & Forecasts
Jun 20, 2018
Neovasc Announces First Implant of a Neovasc Reducer(TM) in a U.S. Patient
Apr 25, 2018
BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina
Feb 28, 2018
Study shows high-sensitivity cardiac troponin I concentration, measured with the Singulex cTnI assay, is an independent predictor of obstructive coronary artery disease in patients with suspected stable angina
Feb 01, 2018
Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer(TM) Procedure for Treatment of Refractory Angina
Jan 18, 2018
Neovasc Reducer Featured in Live Case at Berlin Symposium
Jan 14, 2018
Upstream Medical Sources Global Funding for Novel Diagnostic Platform Clinical Trial
Jan 08, 2018
Taxus Cardium Announces Name Change To Gene Biotherapeutics
Dec 14, 2017
United States Transmyocardial Revascularization Devices Markets 2017-2018: AHA Estimates Approximately 9.8 Million Americans Experience Angina Symptoms
Dec 12, 2017
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Dec 07, 2017
Global Angina Pectoris Drugs Market Size Worth $10.6 Billion by 2022: Grand View Research, Inc.